Harmonisation of critical OTC derivatives data elements (other than UTI and UPI) – second batch - Consultative report issued by CPMI-IOSCO

20 October 2016

The report responds to the G20’s agreement in 2009 that all OTC derivatives contracts would be reported to TRs, as part of the G20’s commitment to reforming OTC derivatives markets with the aim of improving transparency, mitigating systemic risk and preventing market abuse.

This consultative report is part of the Harmonisation Group’s response to that mandate. It complements the consultative report on Harmonisation of key OTC derivatives data elements (other than UTI and UPI) – first batch Harmonisation of the Unique Transaction Identifier Harmonisation of the Unique Product Identifieras well as the consultative report on and two consultative reports on . The Harmonisation Group also plans to issue consultative reports on further batches of key data elements (other than UTI and UPI) in the coming months.

The report seeks general and specific comments and suggestions from respondents by 30 November 2016.

Full report

© IOSCO